Financials

Company Profile

ATech (Parent) Resolution Corp., formerly Akoustis Technologies, Inc., is not engaged in any business operating activity. The Company has no assets.

Employees

Sector

07-10	Aktis Oncology Insider Sold Shares Worth $1,388,701, According to a Recent SEC Filing	MT
07-10	Aktis Oncology Insider Sold Shares Worth $1,387,558, According to a Recent SEC Filing	MT
06-16	Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target	MT
05-22	Top Premarket Gainers	MT
05-11	Earnings Flash (AKTS) Aktis Oncology, Inc. Reports Q1 Revenue $3.2M	MT
04-29	William Blair Initiates Aktis Oncology at Outperform	MT
03-30	Aktis Oncology Receives US FDA Approval for AKY-2519 Investigational New Drug Applications	MT
03-09	HC Wainwright Initiates Aktis Oncology at Buy With $30 Price Target	MT
02-24	Aktis Oncology Says US FDA Grants Fast Track Designation to AKY-1189 for Urothelial Cancer	MT
02-03	BofA Securities Initiates Coverage on Aktis Oncology With Buy Rating, $34 Price Target	MT
02-03	JPMorgan Initiates Aktis Oncology at Overweight With $30 Price Target	MT
02-03	TD Cowen Initiates Aktis Oncology at Buy	MT
02-03	Leerink Partners Initiates Aktis Oncology at Outperform With $31 Price Target	MT

06-16	Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target	MT
04-29	William Blair Initiates Aktis Oncology at Outperform	MT
03-09	HC Wainwright Initiates Aktis Oncology at Buy With $30 Price Target	MT
02-03	BofA Securities Initiates Coverage on Aktis Oncology With Buy Rating, $34 Price Target	MT
02-03	JPMorgan Initiates Aktis Oncology at Overweight With $30 Price Target	MT

24-12-16	Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process	GL
24-12-16	Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process	BU
24-12-02	Akoustis Technologies : Material Event Form 8 K	PU
24-11-15	Akoustis: Fiscal Q1 Earnings Snapshot	AQ
24-10-28	Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG	AQ

Manager	Title	Age	Since
Robert Dry COO	Chief Operating Officer	-	-
Mary Winters COO	Chief Operating Officer	-	-
Colin Hunt SAM	Sales & Marketing	-	2020-06-01

Director	Title	Age	Since
Jerry Neal CHM	Chairman	82	2016-03-13
Arthur Geiss CHM	Chairman	73	2016-03-13
Jill Frizzley BRD	Director/Board Member	50	2024-08-06

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AKOUSTIS TECHNOLOGIES INC	+12.50%	-10.00%	-	-	155
BOXABL INC.	-1.93%	+16.24%	-53.83%	-	13.74B
FREENOME, INC.	+11.61%	-2.02%	+5.49%	-	1.26B
CHURCHILL CAPITAL CORP XI	+11.62%	+12.76%	-	-	772M
CENTIEL AG	-1.62%	-10.09%	+262.44%	-69.24%	621M
CHURCHILL CAPITAL CORP XII	+1.13%	-0.28%	-	-	607M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.20%	-	-	597M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	-0.38%	-	-	595M
DEEP FISSION, INC.	+5.42%	+1.33%	-	-	568M
Average	+4.28%	+2.56%	+71.37%	-69.24%	2.34B
Weighted average by Cap.	-0.02%	+12.07%	-36.47%	-69.24%